Clinical trials
Kidney Diseases trials in Denmark
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
46 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2010 | 5 |
| 2011 | 3 |
| 2012 | 2 |
| 2014 | 2 |
| 2015 | 5 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
| Recruiting | 6 |
| Unknown status | 4 |
| Active, not recruiting | 2 |
| Not yet recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Regional Hospital Holstebro | 6 |
| Rigshospitalet, Denmark | 5 |
| Steno Diabetes Center Copenhagen | 4 |
| Erling Bjerregaard Pedersen | 3 |
| University of Aarhus | 3 |
| AstraZeneca | 2 |
| Bayer | 2 |
| Aalborg University Hospital | 1 |
| Action Pharma A/S | 1 |
| Alessandro Doria | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kidney Diseases | 46 |
| Cardiovascular Diseases | 8 |
| Renal Insufficiency, Chronic | 8 |
| Diabetic Nephropathies | 6 |
| Coronary Artery Disease | 5 |
| Diabetes Mellitus, Type 2 | 5 |
| Diabetes Mellitus | 4 |
| Diabetes Mellitus, Type 1 | 4 |
| Renal Insufficiency | 4 |
| Heart Diseases | 3 |
Trials
Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.